Thursday, May 01, 2014

New books about 'missing data in clinical trials'

Missing data is one of the critical issues in statistics and in clinical trials. Three new books about the missing data were written by the biostatisticians working directly in pharmaceutical and drug development fields. These three books are worth recommending.



    For free books regarding the missing data, the following resources are available: 
    Does FDA or EMA have a preferred method for dealing with missing data for when companies submit new drugs for approval?
    The general trends in handling the missing data:



    No comments: